Evidence map›Paper›PMID 39853801›Full record

ReviewBiology of the cell2025

Organoid Ethical Typology: varieties of three-dimensional stem cell constructs and the many issues they raise in bioethics.

Maxence Gaillard, Charles H Pence, Mylène Botbol-Baum

Abstract readReview
In one paragraph

Review in Biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Reply: Lung organoids: a new frontier in neonatology and paediatric respiratory medicine.European respiratory review : an official journal of the European Respiratory Society · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maxence GaillardCentre for Medical Ethics, Oslo (Norway) & Institut supérieur de philosophie, University of Oslo, UCLouvain, Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0002-4741-4564
Charles H PenceInstitut supérieur de philosophie, UCLouvain, Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0002-6836-6047
Mylène Botbol-BaumInstitut supérieur de philosophie, UCLouvain, Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0001-6545-4925

Funding

EU H2020 HYBRIDA Project 101006012Research Council of Norway 262613
6 · The paper itself

Abstract

The advancement of and prospects for stem cell research raise a number of specific ethical issues. While navigating the ethical landscape of stem cell research is often challenging for biology researchers and biotechnology innovators, it is also difficult for the public and other persons of concern (from ethicists to policy-makers) to grasp the technicalities of a burgeoning field that develops in many directions. Organoids are one of these new biotechnological constructs that are currently eliciting a rich debate in bioethics. In this guide, we argue that different types of organoids have different emerging properties with different ethical implications. Going from general properties to particular ones, we propose a typology of organoid technology and other associated biotechnology from a philosophical and ethical perspective. We point to relevant ethical issues and try to convey the sense of uncertainty peculiar to ongoing research and emerging technological objects.

Indexed as

BioethicsOrganoidsStem Cell ResearchStem CellsAnimalsBiotechnologyHumansbioethicsbiotechnologyethics of science and medicineorganoidsstem cells

Identifiers

PMID39853801
PMCPMC11758490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.